Sex differences in marijuana use in the United States

Harvard Review of Psychiatry

Volumn 6, Issue 6, 1999, Pages 297-303

  Greenfield, Shelly F ^a   O'Leary, Grace ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHITIS; CANCER RISK; CANCER SUSCEPTIBILITY; CANNABIS ADDICTION; COGNITIVE DEFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SEX DIFFERENCE; UNITED STATES;

EID: 0033067352     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229909017207     Document Type: Review

References (62)

1. Anthony JC, Warner LA, Kessler RC. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994;2:244-68.
2. Substance Abuse and Mental Health Services Administration. Substance use among women in the United States. Rockville, Maryland: Department of Health and Human Services, 1997.
3. Center on Addiction and Substance Abuse at Columbia University. Substance abuse and the American woman. New York: CASA, 1996.
4. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996;91:1585-614.
5. Leonard BE. Cannabis: a short review of its effects and the possible dangers of its use. Br J Addict Alcohol Other Drugs 1969;64:121-30.
6. Van Etten ML, Neumark YD, Anthony JC. Initial opportunity to use marijuana and the transition to first use: United States, 1979-1994. Drug Alcohol Depend 1997;49:1-7.
7. Kandel D, Faust R. Sequence and stages in patterns of adolescent drug use. Arch Gen Psychiatry 1975;32:923-32.
8. Adler I, Kandel DB. Cross-cultural perspectives on developmental stages in adolescent drug use. J Stud Alcohol 1981; 42:701-15.
9. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood, II: Sequences of progression. Am J Public Health 1984;74:668-72.
10. Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood, III: Predictors of progression. Am J Public Health 1984;74:673-81.
11. Warren CW, Kann L, Small ML, Santelli JS, Collins JL, Kolbe LJ. Age of initiating selected health-risk behaviors among high school students in the United States. J Adolesc Health 1997;21:225-31.
12. Kandel DB, Yamaguchi K, Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 1992;53:447-57.
13. Kandel DB. Marijuana users in young adulthood. Arch Gen Psychiatry 1984;41:200-9.
14. Greenfield SF. Women and substance use disorders. In: Jensvoid MF, Halbreich U, Hamilton JA, eds. Psychopharmacology and women: sex, gender, and hormones. Washington, DC: American Psychiatric Press, 1996:299-321.
15. Kendler KS, Prescott CA. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 1998;155:1016-22.
16. Lex BW, Griffin ML, Mello NK, Mendelson JH. Concordant alcohol and marihuana use in women. Alcohol 1986;3: 193-200.
17. Mello NK, Mendelson JH. Operant acquisition of marihuana by women. J Pharmacol Exp Ther 1985;235:162-71.
18. Griffin ML, Mendelson JH, Mello NK, Lex BW. Marihuana use across the menstrual cycle. Drug Alcohol Depend 1986;18: 213-24.
19. Grinspoon L, Bakalar JB. Marihuana. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG, eds. Substance abuse: a comprehensive textbook. 3rd ed. Baltimore: Williams & Wilkins, 1997:199-206.
20. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, De Costa BR, et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990;87:1932-6.
21. Greenfield SF, Weiss RD, Mirin SM. Psychoactive substance use disorders. In: Gelenberg AJ, Bassuk EL, eds. The practitioner's guide to psychoactive drugs. 4th ed. New York: Plenum, 1997:291-363.
22. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Depend 1996;42:201-7.
23. Varma VK, Malhotra AK, Dang R, Das K, Nehra R. Cannabis and cognitive functions: a prospective study. Drug Alcohol Depend 1988;21:147-52.
24. Mendhiratta SS, Varma VK, Dang R, Malhotra AK, Das K, Nehra R. Cannabis and cognitive functions: a re-evaluation study. Br J Addict 1988;83:749-53.
25. Block RI, Ghoneim MM. Effects of chronic marijuana use on human cognition. Psychopharmacology 1993;110:219-28.
26. Pope HG Jr, Yurgelun-Todd D. The residual cognitive effects of heavy marijuana use in college students. JAMA 1996;275: 521-7.
27. Pope HG Jr, Jacobs A, Mialet JP, Yurgelun-Todd D, Gruber S. Evidence for a sex-specific residual effect of cannabis on visuo-spatial memory. Psychother Psychosom 1997;66:179-84.
28. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988;318:347-51.
29. Gong H Jr, Fligiel S, Tashkin DP, Barbers RG. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis 1987;136:142-9.
30. Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998;157:928-37.
31. Taylor FM III. Marijuana as a potential respiratory tract carcinogen. South Med J 1988;81:1213-6.
32. Caplan GA, Brigham BA. Marijuana smoking and carcinoma of the tongue: is there an association? Cancer 1990;66:1005-6.
33. Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997;8:722-8.
34. Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med 1974;290:872-4.
35. Mendelson JH, Kuehnle J, Ellingboe J, Babor TF. Plasma testosterone levels before, during and after chronic marihuana smoking. N Engl J Med 1974;291:1051-5.
36. Mendelson JH, Ellingboe J, Kuehnle JC, Mello NK. Effects of chronic marihuana use on integrated plasma testosterone and luteinizing hormone levels. J Pharmacol Exp Ther 1978;207: 611-7.
37. Block RI, Farinpour R, Schlechte JA. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend 1991;28:121-8.
38. Mendelson JH, Mello NK, Ellingboe J, Skupny AST, Lex BW, Griffin M. Marihuana smoking suppresses luteinizing hormone in women. J Pharmacol Exp Ther 1986;237:862-6.
39. Mendelson JH, Mello NK, Lex BW, Bavli S. Marijuana with drawal syndrome in a woman. Am J Psychiatry 1984;141: 1289-90.
40. Bensusan AD. Marihuana withdrawal symptoms. BMJ 1971; 3:112.
41. Kaymakcalan S. The addictive potential of cannabis. Bull Narc 1981;33:21-31.
42. Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 1996; 91:1469-78.
43. 9-tetrahydrocannabinol [Letter]. N Engl J Med 1969;281:330.
44. Zuckerman B, Frank DA, Hingson R, Amaro H, Levenson SM, Kayne H, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762-8.
45. Williams MA, Lieberman E, Mittendorf R, Monson RR, Schoenbaum SC. Risk factors for abruptio placentae. Am J Epidemiol 1991;134:965-72.
46. Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 1984;150:23-7.
47. Gibson GT, Baghurst PA, Colley DP. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy. Aust NZJ Obstet Gynaecol 1983;23:15-9.
48. Hingson R, Alpert JJ, Day N, Dooling E, Kayne H, Morelock S, et al. Effects of maternal drinking and marijuana use on fetal growth and development. Pediatrics 1982;70:539-46.
49. Linn S, Schoenbaum SC, Monson RR, Rosner R, Stubblefield PC, Ryan KJ. The association of marijuana use with outcome of pregnancy. Am J Public Health 1983;73:1161-4.
50. Fried PA. Marihuana use by pregnant women and effects on offspring: an update. Neurobehav Toxicol Teratol 1982;4: 451-4.
51. Fried PA. Prenatal exposure to marihuana and tobacco during infancy, early and middle childhood: effects and an attempt at synthesis. Arch Toxicol Suppl 1995;17:233-60.
52. Halikas JA, Goodwin DW, Guze SB. Marihuana use and psychiatric illness. Arch Gen Psychiatry 1972;27:162-5.
53. Weller RA, Halikas JA. Marijuana use and psychiatric illness: a follow-up study. Am J Psychiatry 1985;142:848-50.
54. Kouri E, Pope HG Jr, Yurgelun-Todd D, Gruber S. Attributes of heavy vs occasional marijuana smokers in a college population. Biol Psychiatry 1995;38:475-81.
55. Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991;148:224-30.
56. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand 1992;85: 127-30.
57. Gruber AJ, Pope HG Jr, Brown ME. Do patients use marijuana as an antidepressant? Depression 1996;4:77-80.
58. Gruber AJ, Pope HG. Cannabis-related disorders. In: Tasman A, Kay J, Lieberman JA, eds. Psychiatry. Philadelphia: Saunders, 1997:795-806.
59. Millman RB, Beeder AB. Cannabis. In: Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. Washington, DC: American Psychiatric Press, 1994:91-110.
60. Miller NS, Gold MS, Pottash AC. A 12-step treatment approach for marijuana (cannabis) dependence. J Subst Abuse Treat 1989;6:241-50.
61. Zweben JE, O'Connell K. Strategies for breaking marijuana dependence. J Psychoactive Drugs 1988;20:121-7.
62. Roffman RA, Stephens RS, Simpson EE, Whitaker DL. Treatment of marijuana dependence: preliminary results. J Psychoactive Drugs 1988;20:129-37.